Quality manufacturing, extraordinary care
Frontida BioPharm, Inc. is a US-based, minority-owned CDMO providing drug delivery technologies, product development, and manufacturing services for pharmaceutical and consumer health companies. Our experts are dedicated to helping clients and partners reach the market as quickly and efficiently as possible. Frontida supports pharmaceutical companies in the development, scale-up and commercial manufacturing of immediate and controlled-release oral solid dose, powder and liquid products; ensuring robust product performance and on-time supply of clinical trial materials and commercial products.

Our 325,000+ sq. ft. manufacturing facilities located in Philadelphia, PA and Aurora, IL offer a comprehensive suite of solutions for the development and commercialization of prescription, OTC, Highly Potent Active compounds, Phase I through Phase III clinical trial materials, Fixed-dose Combination products and DEA schedule II – V products. Frontida is equipped with multiple world-class commercial packaging lines, capable of validated product serialization, and providing packaging services for both commercial products and clinical trial material supplies in bottles and blisters. Frontida has an annual capacity to manufacture up to 3 billion tablets and capsules. Our highly experienced industry-leading team of professionals offer a number of available technologies and solutions that facilitate the commercialization of high-quality products.
For more information, please contact Frontida at BD@Frontidabiopharm.com or Call +1 (215) 807-1350.


Driven by a culture of caring, accountability, innovation, and quality, Frontida’s leadership team has the demonstrated experience to ensure the successful commercialization of our clients’ products. We are committed to building a dynamic US-based pharmaceutical company that contributes to the well-being of consumers, employees, and our communities.
Song Li, Ph.D.
Founder of Frontage Laboratories, ranked as one of the best service providers in the pharmaceutical industry in the USA and China.
Anthony Qu, Ph.D.
Chief Operating Officer
30+ years’ experience in pharmaceutical industries and worked companies such as Patheon, Apotexand Halo pharma etc.
Puneet Sapra
Chief Financial Officer
Over 20 years of industry experience via executive roles. Expertise in commercial, operational, and strategic finance.
Ron Connolly
EVP, Business Development, Alliances and Regulatory
30 years of product development, scale-up and commercialization experience for pharmaceutical products; project leadership for many first time approvals of APIs.
renard jackson frontida
Renard Jackson
EVP, CMO Operations
30+ years in executive leadership, business development and P&L management.

Praful Agrawala, Ph.D.
EVP, Technology
25+ years experience with clinical and commercial product development in multiple dosage forms.
Read More
Ulrike (Uli) Foley
VP, Business Development
20+ years pharmaceutical experience in commercial and contract manufacturing business development for finished dosage of injectables, SOD, semi-solids, and Inhalation drug development.
Tony Liu, Ph.D.
15+ years experience developing NDA and ANDA products with focus on developing robust commercial manufacturing processes.
Wenyong Wang, Ph.D.
VP, Corporate Development
20+ years of proven track record and experience in healthcare and life sciences industries from R&D, business development to investment banking.
Jim McAndrew
VP, Aurora Operations
25+ years experience includes both branded drug R&D and production, as well as contract development and manufacturing.
Steven H. Roese
VP, Quality
Proven expertise in Quality Assurance, Compliance, Quality Control, and Quality Systems. 25 years of experience with pharmaceutical formulations, medical devices and nutraceuticals, having worked at Abbott Labs, Wyeth Pharmaceuticals, and Array Biopharma.

Team Member Perspectives

I believe that my ideas and opinions mean something and because of this I am encouraged and excited to contribute wherever I can to help Frontida achieve all the success it has the potential for.
Dominick Castaldo
Director - R&D, Technical Services